Invention Application
- Patent Title: Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
-
Application No.: US17748629Application Date: 2022-05-19
-
Publication No.: US20220372129A1Publication Date: 2022-11-24
- Inventor: Matthew Germinaro , Christopher O'Brien , Jacqueline Perrigoue , Marion Vetter
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P1/04 ; A61K38/17 ; A61K39/395
Abstract:
A method of treating inflammatory bowel disorders, such as ulcerative colitis, comprises administering an IL-23 inhibitor, such as an anti-IL-23p19 antibody (e.g., guselkumab) and a TNFα inhibitor, such as an anti-TNFα antibody (e.g., golimumab).
Information query
